Apolipoprotein(a) Genetic Sequence Variants Associated With Systemic Atherosclerosis and Coronary Atherosclerotic Burden But Not With Venous Thromboembolism

Objectives The purpose of this study is investigate the effects of variants in the apolipoprotein(a) gene ( LPA ) on vascular diseases with different atherosclerotic and thrombotic components. Background It is unclear whether the LPA variants rs10455872 and rs3798220, which correlate with lipoprotei...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology Vol. 60; no. 8; pp. 722 - 729
Main Authors: Helgadottir, Anna, MD, PhD, Gretarsdottir, Solveig, PhD, Thorleifsson, Gudmar, PhD, Holm, Hilma, MD, Patel, Riyaz S., MD, Gudnason, Thorarinn, MD, PhD, Jones, Gregory T., PhD, van Rij, Andre M., MD, Eapen, Danny J., MD, Baas, Annette F., PhD, Tregouet, David-Alexandre, PhD, Morange, Pierre-Emmanuel, MD, Emmerich, Joseph, MD, PhD, Lindblad, Bengt, MD, PhD, Gottsäter, Anders, MD, PhD, Kiemeny, Lambertus A., PhD, Lindholt, Jes S., MD, PhD, Sakalihasan, Natzi, MD, PhD, Ferrell, Robert E., PhD, Carey, David J., PhD, Elmore, James R., MD, Tsao, Philip S., PhD, Grarup, Niels, MD, PhD, Jørgensen, Torben, MD, DMSci, Witte, Daniel R., MD, PhD, Hansen, Torben, MD, PhD, Pedersen, Oluf, MD, DMSci, Pola, Roberto, MD, PhD, Gaetani, Eleonora, MD, Magnadottir, Hulda B., MD, Wijmenga, Cisca, PhD, Tromp, Gerard, PhD, Ronkainen, Antti, MD, PhD, Ruigrok, Ynte M., MD, Blankensteijn, Jan D, Mueller, Thomas, MD, Wells, Philip S., MD, Corral, Javier, PhD, Soria, Jose Manuel, PhD, Souto, Juan Carlos, MD, PhD, Peden, John F., PhD, Jalilzadeh, Shapour, MD, PhD, Mayosi, Bongani M., DPhil, Keavney, Bernard, MD, Strawbridge, Rona J., PhD, Sabater-Lleal, Maria, PhD, Gertow, Karl, PhD, Baldassarre, Damiano, PhD, Nyyssönen, Kristiina, PhD, Rauramaa, Rainer, MD, PhD, Smit, Andries J., MD, PhD, Mannarino, Elmo, MD, Giral, Philippe, MD, Tremoli, Elena, PhD, de Faire, Ulf, MD, PhD, Humphries, Steve E., PhD, Hamsten, Anders, MD, PhD, Haraldsdottir, Vilhelmina, MD, Olafsson, Isleifur, MD, PhD, Magnusson, Magnus K., MD, Samani, Nilesh J., MD, Levey, Allan I., MD, PhD, Markus, Hugh S., MD, Kostulas, Konstantinos, MD, PhD, Dichgans, Martin, MD, Berger, Klaus, MD, Kuhlenbäumer, Gregor, MD, Ringelstein, E. Bernd, MD, Stoll, Monika, PhD, Seedorf, Udo, PhD, Rothwell, Peter M., MD, PhD, Powell, Janet T., MD, Kuivaniemi, Helena, MD, PhD, Onundarson, Pall T., MD, Valdimarsson, Einar, MD, Matthiasson, Stefan E., MD, PhD, Gudbjartsson, Daniel F., PhD, Thorgeirsson, Guðmundur, MD, PhD, Quyyumi, Arshed A., MD, Watkins, Hugh, MD, PhD, Farrall, Martin, MD, Thorsteinsdottir, Unnur, PhD, Stefansson, Kari, MD, PhD
Format: Journal Article Web Resource
Language:English
Published: New York, NY Elsevier Inc 21-08-2012
Elsevier
Elsevier Limited
Subjects:
Age
SVD
VTE
SNP
IA
MI
AAA
CE
OR
CI
CAD
LAA
IMT
n e
PAD
LPA
ne
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives The purpose of this study is investigate the effects of variants in the apolipoprotein(a) gene ( LPA ) on vascular diseases with different atherosclerotic and thrombotic components. Background It is unclear whether the LPA variants rs10455872 and rs3798220, which correlate with lipoprotein(a) levels and coronary artery disease (CAD), confer susceptibility predominantly via atherosclerosis or thrombosis. Methods The 2 LPA variants were combined and examined as LPA scores for the association with ischemic stroke (and TOAST [Trial of Org 10172 in Acute Stroke Treatment] subtypes) (effective sample size [ ne ] = 9,396); peripheral arterial disease ( ne = 5,215); abdominal aortic aneurysm ( ne = 4,572); venous thromboembolism ( ne = 4,607); intracranial aneurysm ( ne = 1,328); CAD ( ne = 12,716), carotid intima-media thickness (n = 3,714), and angiographic CAD severity (n = 5,588). Results LPA score was associated with ischemic stroke subtype large artery atherosclerosis (odds ratio [OR]: 1.27; p = 6.7 × 10–4 ), peripheral artery disease (OR: 1.47; p = 2.9 × 10–14 ), and abdominal aortic aneurysm (OR: 1.23; p = 6.0 × 10–5 ), but not with the ischemic stroke subtypes cardioembolism (OR: 1.03; p = 0.69) or small vessel disease (OR: 1.06; p = 0.52). Although the LPA variants were not associated with carotid intima-media thickness, they were associated with the number of obstructed coronary vessels (p = 4.8 × 10–12 ). Furthermore, CAD cases carrying LPA risk variants had increased susceptibility to atherosclerotic manifestations outside of the coronary tree (OR: 1.26; p = 0.0010) and had earlier onset of CAD (–1.58 years/allele; p = 8.2 × 10–8 ) than CAD cases not carrying the risk variants. There was no association of LPA score with venous thromboembolism (OR: 0.97; p = 0.63) or intracranial aneurysm (OR: 0.85; p = 0.15). Conclusions LPA sequence variants were associated with atherosclerotic burden, but not with primarily thrombotic phenotypes.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
scopus-id:2-s2.0-84865125773
ISSN:0735-1097
1558-3597
1558-3597
DOI:10.1016/j.jacc.2012.01.078